Fidelity Fd.S.Health C.Fd.Y Acc USD
LU2078916223
Fidelity Fd.S.Health C.Fd.Y Acc USD/ LU2078916223 /
NAV2024-08-26 |
Chg.0.0000 |
Type of yield |
Investment Focus |
Investment company |
15.9600USD |
0.00% |
reinvestment |
Equity
Worldwide
|
FIL IM (LU) ▶ |
Investment strategy
The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics.
In actively managing the fund, the Investment Manager considers growth and valuation metrics, company financials, return on capital, cash flows and other measures, as well as company management, industry, economic conditions, and other factors. The Investment Manager also considers ESG characteristics when assessing investment risks and opportunities. In determining favourable ESG characteristics, the Investment Manager takes into account ESG ratings provided by Fidelity or external agencies. Through the investment management process, the Investment Manager aims to ensure that investee companies follow good governance practices. The fund assesses the ESG characteristics of at least 90% of its assets. When selecting investments, the fund"s investment universe will be reduced by at least 20% after excluding issuers based on their ESG characteristics. The fund adheres to the Fidelity Sustainable Family of Funds standards.
Investment goal
The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Health / Pharma |
Benchmark: |
MSCI ACWI Health Care Index (Net) |
Business year start: |
05-01 |
Last Distribution: |
- |
Depository bank: |
Brown Brothers Harriman (Lux) S.C.A. |
Fund domicile: |
Luxembourg |
Distribution permission: |
Austria, Germany, Switzerland, Czech Republic |
Fund manager: |
Alex Gold |
Fund volume: |
1.71 bill.
EUR
|
Launch date: |
2019-11-13 |
Investment focus: |
- |
Conditions
Issue surcharge: |
0.00% |
Max. Administration Fee: |
0.80% |
Minimum investment: |
2,500.00 USD |
Deposit fees: |
0.35% |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
FIL IM (LU) |
Address: |
Kärntner Straße 9, Top 8, 1010, Wien |
Country: |
Austria |
Internet: |
www.fidelity.at
|
Assets
Stocks |
|
97.00% |
Mutual Funds |
|
2.65% |
Cash |
|
0.32% |
Others |
|
0.03% |
Countries
United States of America |
|
64.15% |
Denmark |
|
9.25% |
United Kingdom |
|
6.81% |
Switzerland |
|
6.14% |
France |
|
3.89% |
Ireland |
|
3.69% |
Belgium |
|
1.65% |
Japan |
|
1.28% |
Cash |
|
0.32% |
Cayman Islands |
|
0.14% |
Others |
|
2.68% |
Branches
Pharma/Biotechnology |
|
34.41% |
Healthcare services |
|
34.32% |
Healthcare appliances |
|
25.93% |
Parma, wholesale |
|
2.34% |
Cash |
|
0.32% |
Others |
|
2.68% |